Retatrutide is a new pharmaceutical in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating these receptors, Retatrutide reduces hunger pangs, {promotesglucose regulation, and ultimately results in significant weight loss. While fu… Read More